findmyKOL

Michael Biersmith, MD

Basic profile

Interventional Cardiology

ORCIDNPI
RegionHermitage, TN · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Biersmith is a Cardiology physician. OpenAlex indexes 15 publications with 359 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex, matched via ORCID.

359citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
42companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5651 Frist Blvd Ste 603
Hermitage, TN 370762079

Telephone

625-889-1968

Provider last certified this registry record 24 Jan 2024.

View the NPPES registry record

Industry payments

42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    68.7%
    Beta blocker20%
    Metoprolol Succinate36%Carvedilol30%Metoprolol Tartrate24%Sotalol5%Bisoprolol Fumarate3%Atenolol2%
    Part D<11 patients
    Statin13.6%
    Atorvastatin Calcium75%Rosuvastatin Calcium21%Pravastatin Sodium4%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    25.6%
    Factor Xa inhibitor15.7%
    Eliquis75%Xarelto25%
    Part D97 patients
    P2Y12 inhibitor9.9%
    Clopidogrel92%Brilinta8%
    Part D96 patients
  • Metabolism & gastrointestinal

    5.7%
    SGLT2 inhibitor4.8%
    Jardiance57%Farxiga43%
    Part D23 patients
    Potassium supplement0.8%
    Potassium Chloride100%
    Part D11 patients
Where care is delivered (Part B)49.8% facility · 50.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”